Frankfurt-am-Main, Germany

Mark Brönstrup


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Mark Brönstrup

Introduction

Mark Brönstrup is a prominent inventor based in Frankfurt-am-Main, Germany. Known for his contributions to the pharmaceutical field, Brönstrup has secured two patents that showcase his innovative approaches to addressing critical health challenges. His work primarily focuses on novel compounds that can potentially offer therapeutic solutions for various neurological disorders.

Latest Patents

Mark Brönstrup's latest patents include groundbreaking inventions in the pharmaceutical sector:

1. **Hydroxyphenylundecane**: This invention relates to novel hydroxyphenylundecane derivatives, derived from the cultivation of the fungus DSM 14453. The patent details a method for the production of these compounds and their application in treating diseases such as Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, stroke, psychosis, and depressions.

2. **Citrullimycines**: Another significant patent by Brönstrup is focused on Citrullimycines, active compounds obtainable through the cultivation of the microorganism sp. ST 101396 (DSM 13309). The invention discusses a process for their production, alongside their therapeutic uses, specifically as inhibitors of the neurotensin receptor. This discovery furthers the potential of Citrullimycines and their pharmaceutically acceptable salts and derivatives in providing medicinal solutions.

Career Highlights

Throughout his career, Mark Brönstrup has worked with reputable companies such as Sanofi Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His involvement in these organizations has significantly impacted his research and development efforts, allowing him to contribute valuable inventions to the pharmaceutical industry.

Collaborations

In his professional journey, Brönstrup has collaborated with notable colleagues, including Cordula Hopmann and Martin Knauf. These partnerships have fostered a collaborative environment that enhances innovation and the development of novel solutions in pharmaceuticals.

Conclusion

Mark Brönstrup stands out as an inventor dedicated to tackling complex medical issues through innovative research and development. His patents not only illustrate his commitment to improving healthcare but also highlight his ability to create valuable solutions with the potential to impact countless lives positively. With a focus on neurological health, Brönstrup's contributions represent a significant advancement in the pharmaceutical field, demonstrating the power of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…